3rd regenerative medicine
orthopaedic summit
3rd regenerative medicine
orthopaedic summit
November 30th to December 2nd, 2023
Istanbul, Turkey
About RMOS
The Regenerative Medicine Orthopaedic Society (RMOS) was brought to life in 2022 by Prof. Tahsin Beyzadeoglu and Ass. Prof. George Skarpas, both renowned figures in the orthopaedic field. Fueled by a shared conviction in the potential of regenerative medicine to revolutionize orthopaedics, they saw the need for a dedicated forum to promote, explore, and advance this innovative field.
Their vision became the blueprint for RMOS – an organization dedicated to transforming orthopaedic care through regenerative medicine. In this pursuit, we are guided by an unwavering commitment to scientific integrity, patient welfare, and the creation of an inclusive, collaborative community.
Our society is a vibrant and diverse network of orthopaedic surgeons, researchers, healthcare professionals, biotech firms, and policy advocates. This broad coalition brings together complementary skills, experiences, and perspectives, fostering an environment that encourages learning, knowledge exchange, and collaboration. Each member contributes uniquely to the evolution of our field and benefits from the shared knowledge and opportunities provided by the society.
Since our inception, RMOS has been at the forefront of breakthroughs in regenerative medicine applied to orthopaedics. We have conducted successful international summits, bringing together experts from around the world to share insights and drive progress. These gatherings have served as vital platforms for knowledge dissemination, idea generation, and collaborations that propel the advancement of regenerative medicine within orthopaedics.
Our success has also been fueled by significant collaborations with other organizations, academic institutions, and industry partners. These strategic alliances have not only expanded our reach but also enriched our resources and capabilities. Together, we strive to navigate the challenges and opportunities in our path to ensure that regenerative medicine reaches its full potential in orthopaedics.
Looking towards the future, RMOS is committed to building upon its robust foundation. We aim to expand our global footprint, increase membership, boost our research contributions, and enhance our educational programs. Above all, we continue to prioritize our central goal – to improve patient outcomes and quality of life by incorporating regenerative medicine in the standard orthopaedic practice.
At RMOS, we believe that our collective efforts will forge a new era in orthopaedics where regenerative therapies become mainstream, marking a significant leap forward in patient care.
Mission of RMOS
Our mission at the Regenerative Medicine Orthopaedic Society (RMOS) is to pioneer the integration of regenerative medicine in orthopaedic care, thereby transforming the way we treat musculoskeletal conditions and injuries. This mission is grounded in four key objectives:
Promotion of Research: We aim to stimulate high-quality, ethical research in regenerative medicine and orthopaedics. We advocate for research that seeks to understand, develop, and refine regenerative therapies for various orthopaedic conditions. Through funding initiatives, collaboration with academic and industry partners, and the provision of research platforms, we endeavor to foster an environment conducive to scientific exploration and innovation.
Dissemination of Knowledge: We are committed to creating and disseminating knowledge about regenerative medicine within the orthopaedic community. Through our summits, publications, online platforms, and educational programs, we share the latest research findings, clinical experiences, and policy developments related to regenerative medicine.
Fostering Collaborations: Recognizing that progress is accelerated through collective effort, we strive to cultivate collaborations among professionals in the field. By facilitating connections between researchers, clinicians, policymakers, and industry leaders, we aim to catalyze the development and application of regenerative medicine in orthopaedics.
Advocacy: We advocate for policies and regulations that support the ethical and effective adoption of regenerative medicine in orthopaedic clinical practice. This includes engagement with healthcare institutions, governmental agencies, and other regulatory bodies to ensure a conducive environment for the implementation of regenerative medicine.
In fulfilling our mission, we at RMOS are driven by a steadfast dedication to improving patient outcomes and advancing the field of orthopaedics. We firmly believe that regenerative medicine represents the future of orthopaedic care, and we are committed to making that future a reality.
Vision of RMOS
Our vision at the Regenerative Medicine Orthopaedic Society (RMOS) is to be the global leader in integrating regenerative medicine into orthopaedics, shaping a future where these innovative therapies are a mainstay of musculoskeletal care.
We envision a world where:
- Advanced Therapies: Regenerative therapies are recognized as standard practice for treating a wide range of orthopaedic conditions, offering hope and improved quality of life for patients across the globe.
- Broad Acceptance: Healthcare professionals worldwide acknowledge and adopt the use of regenerative medicine, equipped with the necessary knowledge and skills for its safe and effective application.
- Groundbreaking Research: RMOS is at the forefront of groundbreaking research in regenerative medicine and orthopaedics, contributing to the development of new therapies that address unmet needs in patient care.
- Knowledge Sharing: RMOS serves as a premier platform for the exchange of ideas, research findings, and best practices related to regenerative medicine in orthopaedics, accelerating the advancement of the field.
- Collaborative Efforts: We are a vibrant, diverse, and inclusive society where multidisciplinary collaboration thrives, sparking innovation and driving progress in the field of regenerative medicine.
- Influence Policy: We actively engage with policy-makers, advocating for regulatory frameworks that promote the safe, ethical, and efficient implementation of regenerative therapies in orthopaedics.
Through our persistent efforts and unwavering commitment, we aim to transform this vision into reality, leading the way in revolutionizing orthopaedic care through regenerative medicine. At RMOS, we aspire to leave a lasting impact on the lives of patients and the future of healthcare.
Founding Story of RMOS
In the field of orthopaedics, progress is driven by the relentless pursuit of innovative and effective treatments. This ethos led two visionary professionals, Prof. Tahsin Beyzadeoglu and Ass. Prof. George Skarpas, to a realization: there was a growing, untapped potential at the intersection of orthopaedics and regenerative medicine. They believed in the transformative power of this field, foreseeing a future where regenerative therapies could revolutionize the care for patients with musculoskeletal conditions.
Motivated by this vision and the urgency to make it a reality, they set out to form a society that would unite like-minded professionals around this cause. Thus, in September 2022, the Regenerative Medicine Orthopaedic Society (RMOS) was born.
Starting as a humble gathering of dedicated professionals, the society was met with enthusiastic support from orthopaedic surgeons, researchers, and other healthcare professionals who shared the same belief in the potential of regenerative medicine. The founders’ passionate advocacy and the founding members’ diverse expertise served as the bedrock for the society’s rapid growth.
The first significant milestone of RMOS came with the organization of the inaugural RMOS Summit in December 2022 in Athens, Greece, spearheaded by Ass. Prof. George Skarpas. The event served as a testament to the society’s vision, bringing together professionals from around the world to share insights, present research, and foster collaborations in the field of regenerative medicine and orthopaedics.
The society’s momentum continued with the second summit in May 2023, held in Naples, Italy, under the stewardship of Dr. Fabio Sciarretta. The event further consolidated RMOS’s standing as a leading force in the field, reinforcing its commitment to the promotion of regenerative medicine in orthopaedics.
Today, as RMOS prepares for its third summit to be held in Istanbul, Turkey, under the leadership of Prof. Tahsin Beyzadeoglu, the society stands as a testament to the enduring vision of its founders. The Regenerative Medicine Orthopaedic Society remains committed to its founding principles, harnessing the power of collective effort, scientific rigor, and innovative thinking to drive the integration of regenerative medicine into orthopaedics.
Our Values at RMOS
The Regenerative Medicine Orthopaedic Society (RMOS) is guided by a set of core values that underpin our work and our interactions within our society and the broader community. These values serve as our compass, shaping our strategies, decisions, and behaviors.
- Scientific Integrity: We uphold the highest standards of scientific rigor and ethical conduct in all our research activities. We believe that robust, reproducible, and transparent research is fundamental to the advancement of regenerative medicine in orthopaedics.
- Patient-Centered Approach: Our ultimate goal is to improve patient outcomes and quality of life. Every decision we make, every project we undertake, and every policy we advocate for is evaluated on how it will impact the patients we serve.
- Innovation: We are committed to fostering an environment that encourages creativity, risk-taking, and innovation. We believe that groundbreaking ideas and techniques are vital to revolutionizing the field of orthopaedic care.
- Collaboration: We recognize that progress is not a solitary endeavor, but a collective effort. We strive to cultivate an inclusive, collaborative community where every member feels valued, heard, and inspired to contribute to our shared mission.
- Education: We are dedicated to facilitating learning and knowledge dissemination within our society and beyond. We believe in empowering healthcare professionals and the public with accurate, up-to-date information about regenerative medicine in orthopaedics.
- Advocacy: We are committed to advocating for regulatory frameworks that support the ethical, safe, and effective application of regenerative medicine in orthopaedic practice. We actively engage with policy-makers and stakeholders to achieve this.
- Respect: We uphold a culture of mutual respect, where diversity of thoughts, experiences, and backgrounds are appreciated and leveraged to enrich our society and the field of orthopaedics.
These values are the pillars of RMOS. They define who we are, what we stand for, and how we strive to make a positive impact in the realm of orthopaedic care. By staying true to these principles, we seek to fulfill our mission and vision, leading the way in transforming orthopaedic care through regenerative medicine.
Our Members at RMOS
Our members are the lifeblood of the Regenerative Medicine Orthopaedic Society (RMOS). Our community consists of dedicated professionals who share a common vision – harnessing the potential of regenerative medicine to revolutionize orthopaedic care. This commitment unites a diverse group of members from various backgrounds and specializations, all of whom contribute uniquely to the collective progress of RMOS and the broader field.
Orthopaedic Surgeons: As the direct providers of patient care, orthopaedic surgeons bring their valuable clinical experiences and insights. They contribute to the development and refinement of regenerative therapies, ensuring that the interventions are practically feasible, safe, and effective.
Researchers: Our community of researchers, from biologists to bioengineers, are at the forefront of exploring the potential of regenerative medicine. Their groundbreaking work is the foundation upon which new therapies are built, driving the field forward through their innovative research.
Healthcare Professionals: We count among our members a range of healthcare professionals including physical therapists, nurses, physician assistants, and more. Their perspectives enrich our understanding of patient needs, help in translating research into practice, and contribute to holistic patient care.
Industry Partners: Biotech firms and pharmaceutical companies play a critical role in translating research breakthroughs into viable treatments. They provide the necessary resources, technical expertise, and infrastructural support to bring regenerative therapies from the laboratory to the patient.
Policy Advocates: These members help navigate the complex regulatory landscape that surrounds regenerative medicine. They advocate for policies that support the adoption of regenerative therapies in clinical practice, ensuring that these innovative treatments can be safely and effectively delivered to patients.
Every member of RMOS, regardless of their background or role, has the opportunity to learn, to contribute, and to collaborate within our community. They gain access to the latest research findings, educational resources, networking opportunities, and platforms for sharing their work. In return, their combined expertise, experiences, and commitment form the driving force behind our society’s growth and the progress of regenerative medicine in orthopaedics.
At RMOS, we believe in the power of our collective effort and are immensely grateful to our members for their invaluable contributions to our shared mission. Together, we are leading the way in transforming orthopaedic care.
Our Achievements at RMOS
Since its establishment in 2022, the Regenerative Medicine Orthopaedic Society (RMOS) has made significant strides towards fulfilling its mission. Here are some of our key achievements:
- Successful International Summits: RMOS has successfully hosted two international summits, the first in Athens, Greece (December 2022), and the second in Naples, Italy (May 2023). These summits have established RMOS as a leading platform for knowledge sharing and collaboration in the field of regenerative medicine in orthopaedics. They have brought together experts from around the world to exchange ideas, share research findings, and foster collaborations.
- Growing Membership: Since our inception, our membership has seen consistent growth, demonstrating the increasing recognition of the potential of regenerative medicine in the orthopaedic community. Our members include a diverse group of orthopaedic surgeons, researchers, healthcare professionals, biotech firms, and policy advocates, forming a dynamic community dedicated to the advancement of regenerative medicine in orthopaedics.
- Influential Research: RMOS members have contributed to groundbreaking research in the field, exploring the potential of regenerative therapies in the treatment of various orthopaedic conditions. Our society provides a platform for members to share their research, driving progress and stimulating further investigation.
- Education and Training Programs: We have launched several education and training programs aimed at equipping healthcare professionals with the necessary knowledge and skills to implement regenerative medicine in their practice. These programs have reached professionals globally, amplifying the impact of RMOS's work.
- Policy Advocacy: RMOS has been instrumental in advocating for policies that promote the adoption of regenerative medicine in orthopaedic practice. Our engagement with policymakers and regulatory bodies has facilitated constructive dialogues and informed decision-making.
- Strategic Collaborations: RMOS has fostered strategic alliances with other organizations, academic institutions, and industry partners. These collaborations have expanded our reach, bolstered our resources, and enabled us to make a larger impact.
While we are proud of our achievements, we recognize that there is still much work to be done. As we look to the future, RMOS remains committed to its mission of integrating regenerative medicine into orthopaedic care, improving patient outcomes, and driving progress in the field.
Our Partners at RMOS
The Regenerative Medicine Orthopaedic Society (RMOS) believes in the power of collaboration to drive progress. We have been fortunate to partner with several organizations that share our vision for the integration of regenerative medicine into orthopaedic care. While our partnerships span across various sectors, each one plays a crucial role in furthering our mission:
- Academic Institutions: Universities and research institutions around the world have collaborated with RMOS to conduct cutting-edge research in regenerative medicine. They have also supported our education and training programs, providing resources and academic expertise.
- Healthcare Providers: Hospitals and clinics have partnered with us to implement and evaluate regenerative therapies in their orthopaedic practice. These partners are vital in translating research into practice and ensuring that innovations in regenerative medicine reach patients.
- Biotech and Pharmaceutical Companies: We have established partnerships with industry leaders who are pioneering the development of regenerative therapies. These partners provide the technical expertise and resources needed to bring new treatments from the lab to the market.
- Non-Profit Organizations: Non-profits focused on health and science have supported our mission in various ways, from funding research initiatives to advocating for patient access to regenerative therapies.
- Governmental and Regulatory Bodies: Collaboration with these partners has been crucial for our advocacy work. They help us navigate the regulatory landscape of regenerative medicine and influence policy decisions that impact the adoption of these therapies in orthopaedic practice.
- Professional Societies: We've established relationships with other professional societies in related fields, allowing for an exchange of knowledge, collaborative research efforts, and joint advocacy initiatives.
Our partners contribute immensely to the work of RMOS, and we are deeply grateful for their support. Through these collaborative relationships, we are able to amplify our impact, bringing us closer to our vision of integrating regenerative medicine into orthopaedic care. We look forward to forging new partnerships and strengthening existing ones as we continue our work.
Our Future Plans at RMOS
As the Regenerative Medicine Orthopaedic Society (RMOS) continues to grow and evolve, we look forward to pursuing several key initiatives aimed at furthering our mission:
Expanding Research Initiatives: We plan to broaden our research scope in regenerative medicine and orthopaedics, focusing on both fundamental and translational research. By supporting multidisciplinary research projects, we hope to catalyze the development of innovative regenerative therapies for a wider range of orthopaedic conditions.
Enhancing Education and Training Programs: We aim to develop more comprehensive and accessible education and training programs. Our goal is to reach a broader audience, including healthcare professionals, students, patients, and the public, to increase awareness and understanding of regenerative medicine in orthopaedics.
Increasing Global Presence: We will continue to grow our membership and establish partnerships worldwide. Hosting more international summits and events is a key part of this strategy, allowing us to bring together global experts, facilitate knowledge exchange, and foster collaborations.
Strengthening Policy Advocacy: We plan to expand our policy advocacy efforts to promote a favorable regulatory environment for regenerative medicine. We will engage more actively with policymakers, regulatory bodies, and other stakeholders, advocating for policies that support the safe and effective use of regenerative therapies in orthopaedic practice.
Developing Patient Outreach Programs: We aim to establish programs that engage directly with patients. These initiatives will focus on educating patients about regenerative therapies, providing resources, and addressing their concerns and queries.
Promoting Industry Collaboration: We intend to strengthen our relationships with biotech and pharmaceutical companies to accelerate the translation of research into clinical practice. Joint efforts in research, development, and clinical trials will ensure that innovative treatments reach patients more quickly.
Building a Digital Platform: We plan to build an online platform that will serve as a repository of information, a networking hub, and a platform for online training and webinars. This digital hub will enable us to reach out to a global audience, expanding our impact.
Sustainability: We aim to ensure the long-term sustainability of RMOS. This includes securing funding for our initiatives, maintaining the engagement and growth of our membership, and continuously adapting to the evolving needs and opportunities in the field of regenerative medicine and orthopaedics.
At RMOS, we remain committed to our mission, and we are excited about the opportunities that lie ahead. Through our efforts, we hope to continue driving progress in the field of regenerative medicine in orthopaedics and improving the lives of patients worldwide.
